- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03878134
Translational Development of Photon-counting CT Imaging
Translational Development of Photon-Counting CT Imaging
Study Overview
Status
Intervention / Treatment
Detailed Description
NIH develops new imaging techniques as one of its priorities for accelerating science, including methods for non-invasive patient assessments. Computed tomographic (CT) imaging is a mainstay of diagnostic imaging. The latest major technological advance is photon counting CT (PCCT) which uses a new x-ray detector that measures x-ray penetration of the body and the energy of each x-ray photon. NIH Clinical Center will use a prototype Siemens PCCT CounT systems built for clinical investigational use. The scanner can perform standard CT and PCCT imaging. In this protocol, NIH patients already enrolled in a clinical research protocol and who are referred to Radiology for diagnostic CT as part of that research may be enrolled in this study of PCCT. The diagnostic CT scan requested by their medical care team will be performed on the CounT scanner, providing the clinically indicated imaging, along with a single abbreviated PCCT exam of an organ or body part to support PCCT feasibility of the PCCT to provide better images in several small groups of patients with selected medical conditions. The data will be used to characterize quality of the PCCT images and to develop testable hypotheses and new diagnostic applications using PCCT capabilities.
Current CT systems, such as the Siemens SOMATOM Flash, have two x-ray tubes, each paired with an x-ray detector that measures total x-ray penetration of the patient and uses that information to create the images. The CounT scanner is a modified version of the Flash in which one of the two standard detectors has been replaced with a PCCT detector. The two imaging modes for the CounT scanner are (i) standard detector study as in a Flash scanner and (ii) PCCT scan. The patient scan will thus include clinically indicated radiation exposure with the standard detector and research radiation over a limited field with the PCCT detector. The CounT system is sited at the Clinical Center under a CRADA (Cooperative research and development agreement) with Siemens Medical Solutions.
Compared to current scanners, PCCT is expected to offer four major advantages:
- lower radiation dose
- greater spatial resolution
- reduced imaging noise
- x-ray energy discrimination
As a translational development protocol, all imaging studies are open-label and data may be analyzed as they are collected.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health Clinical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
- INCLUSION CRITERIA:
- NIH patients currently on an NIH research protocol who are referred to RAD&IS for CT examination as part of that research protocol
- 18 years old or greater
- Able to understand and sign informed consent
EXCLUSION CRITERIA:
- Studies that specifically require simultaneous dual source CT scan capability or where dual source CT scan is requested
- Studies ordered for an emergency indication
- Pregnant women. Subjects of child-bearing potential will undergo serum or urine pregnancy testing within 72 hours before examination. Post-menopausal and surgically sterilized subjects are automatically exempt from this testing
- Lactating women who are unable to stop breast feeding for 24 hours following the administration of contrast
- Body weight >500 lbs (227 kg) or a body circumference that prevents the study subject from lying flat in the scanner
- Patients who have undergone PCCT examination within the past year.
- Any contraindications that the research team identifies from the subject, RAD&IS CT questionnaires, and/or History and Assessment
- Employees or staff supervised by the Principal Investigator or an Associate will not be recruited to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients undergoing conventional and Photon Counting CT scan on the investigational scanner
18 and older patients who undergo the conventional CT scan and the photon counting CT (PCCT) scan.
Patient's images on the conventional scanner provide internal control to compare to the PCCT images.
|
Enrolled patients will undergo the requested clinical diagnostic CT study on the investigational system using the standard detector, with or without IV and/or oral contrast as indicated and an limited scan of one body region using the PCCT detector.
Both scans are able to be performed on the same scanner during the same examination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Difference in Diagnostic Image Quality Grading of Photon Counting CT vs Conventional CT Images.
Time Frame: 2 years and 3 months, 27 months
|
Mean difference in relative image quality grading of CT images using Photon counting detectors vs. conventional detectors in group of patients with various clinical conditions.
Scale name "Visual grading analysis (VGA)" .
Expert radiologist observers compare the relative grades of the images from the PCCT to the grades of the same patient's reference images from conventional CT acquired at the same time.
The visual grading scale incorporates technical factors in the acquisition and image display (such as contrast, noise and presence of artifacts and post processing).
Grading is based on 5 point scale.
1- lowest image quality, 5- highest image quality.
5 is a better result.
Scale as follows: 1 Images not usable- severe limitations for diagnostic use, 2 Limited -some loss of information, significant limitations for clinical use, 3 Adequate -moderate limitations for diagnostic use, 4 Good-minimal limitations for clinical use, 5 Excellent- no limitations for clinical diagnosis.
|
2 years and 3 months, 27 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Optimize and develop Clinical application advancement in CT Technology
Time Frame: 5 years
|
To facilitate the translation of PCCT technology and imaging methods into clinically useful applications for patients.
|
5 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Elizabeth C Jones, M.D., National Institutes of Health Clinical Center (CC)
Publications and helpful links
General Publications
- Symons R, Pourmorteza A, Sandfort V, Ahlman MA, Cropper T, Mallek M, Kappler S, Ulzheimer S, Mahesh M, Jones EC, Malayeri AA, Folio LR, Bluemke DA. Feasibility of Dose-reduced Chest CT with Photon-counting Detectors: Initial Results in Humans. Radiology. 2017 Dec;285(3):980-989. doi: 10.1148/radiol.2017162587. Epub 2017 Jul 28.
- Pourmorteza A, Symons R, Henning A, Ulzheimer S, Bluemke DA. Dose Efficiency of Quarter-Millimeter Photon-Counting Computed Tomography: First-in-Human Results. Invest Radiol. 2018 Jun;53(6):365-372. doi: 10.1097/RLI.0000000000000463.
- Pourmorteza A, Symons R, Reich DS, Bagheri M, Cork TE, Kappler S, Ulzheimer S, Bluemke DA. Photon-Counting CT of the Brain: In Vivo Human Results and Image-Quality Assessment. AJNR Am J Neuroradiol. 2017 Dec;38(12):2257-2263. doi: 10.3174/ajnr.A5402. Epub 2017 Oct 5.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 190070
- 19-CC-0070
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Diseases
-
Terumo Europe N.V.CompletedPeripheral Vascular Disease | Hemostasis | Vascular Closure | Endovascular ProcedureBelgium, France, Germany
-
University Hospital, MontpellierTerminated
-
Alvotech Swiss AGActive, not recruitingChorioretinal Vascular DiseaseGeorgia
-
AmgenCompletedChorioretinal Vascular DiseaseUnited States
-
Duke UniversityTerminatedRetinal Vascular DiseaseUnited States
-
University of California, IrvineUniversity of Oklahoma; US Department of Veterans Affairs; C. R. Bard; Long Beach...CompletedPeripheral Vascular Disease | Cardiac Catheterization | Vascular Access ComplicationsUnited States
-
Baylor UniversityNational Institute on Aging (NIA)RecruitingArterial Occlusive Diseases | Peripheral Arterial Disease | Atherosclerosis | Vascular Diseases, PeripheralUnited States
-
C. R. BardCromsourceCompletedVascular Diseases, PeripheralGermany, Poland
-
Regeneron PharmaceuticalsCompletedChorioretinal Vascular DiseaseUnited States
-
Unity Health TorontoUnknownPeripheral Vascular Disease Patient
Clinical Trials on PHOTON COUNTING CT Scanner
-
Semmelweis UniversityNational Institute of Rheumatology and Physiotherapy, Hungary; Buda Hospital...RecruitingArthritis, Rheumatoid | Arthritis, Psoriatic | Crystal ArthropathiesHungary
-
Reto Sutter, MDNot yet recruitingDiagnostic Imaging | Tomography, X Ray Computed
-
GE HealthcarePrismatic Sensors ABCompleted
-
Region Örebro CountyRecruitingCoronary Stenosis | Calcific Coronary ArteriosclerosisSweden
-
Mayo ClinicNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Active, not recruiting
-
University Medical Center MainzNot yet recruitingCoronary Artery DiseaseGermany
-
GE HealthcareStanford UniversityRecruiting
-
University Hospital AugsburgCompletedPneumonia | Aortic Stenosis | Lung Cancer | Pulmonary Disease | Pulmonary EmbolismGermany
-
Balgrist University HospitalRecruitingStress Fracture Metatarsal | Lower Limb Fracture | Stress Fracture Foot | Stress Fracture Ankle | Stress Fracture of TibiaSwitzerland
-
Hospices Civils de LyonRecruitingCoronary Artery Disease | Diabetes | Joint Diseases | Diabetic Foot Ulcer | Interstitial Lung Disease | Hyperaldosteronism | Kidney Stone | Intracranial Arteriovenous Malformations | Adrenal Incidentaloma | Parenchymatous; Pneumonia | Inner Ear Disease | Brain Stroke | MacroadenomaFrance